ARTICLE | Clinical News
NeXstar regulatory update
July 31, 1995 7:00 AM UTC
NXTR's Vestar Inc. subsidiary (San Dimas, Calif.) received U.S. Patent No. 5,435,989 covering methods for the liposomal targeting of tumors. The patent describes the mechanism of action that enables ...